Skip to main content
logo
MedinCell S.A. (EPA:MEDCL)
France flag France · Delayed Price · Currency is EUR
25.78
-0.16 (-0.62%)
Aug 3, 2026, 12:36 PM CET

MedinCell Financials Overview

Millions EUR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
19.5219.5225.429.039.898.34
Revenue Growth
-31.29%-23.21%181.43%-8.67%18.60%1.86%
Gross Profit
19.5219.5225.429.039.898.34
Operating Income
-25.54-25.54-13.15-23.89-24.05-19.57
Net Income
-31.29-31.29-18.44-25.04-32.01-24.81
Earnings Per Share
-0.94-0.94-0.62-0.88-1.27-1.00
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
84.8284.8271.919.466.4727.18
Total Debt
57.4157.4158.7658.9654.6547.49
Net Cash (Debt)
27.4127.4113.14-39.5-48.18-20.31
Net Cash Growth
-108.61%----
Net Cash Per Share
0.820.820.44-1.39-1.91-0.82

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-24.55-24.5519.47-11.92-21.01-21.36
Capital Expenditures
-0.82-0.82-0.75-0.32-0.58-1.62
Free Cash Flow
-25.37-25.3718.72-12.25-21.58-22.99
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-130.85%-130.85%-51.73%-264.50%-243.16%-234.67%
Pretax Margin
-160.65%-160.65%-71.91%-276.24%-323.69%-246.04%
Profit Margin
-160.30%-160.30%-72.54%-277.21%-323.69%-297.50%
FCF Margin
-129.98%-129.98%73.64%-135.59%-218.23%-275.67%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Forward PE
-93.6827.9668.0068.006.91
P/FCF Ratio
--25.44---
PS Ratio
38.3641.4718.7330.8725.0922.38